ALTIMMUNE, INC. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ALTIMMUNE, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-03-31 was $177.00K, a 4.12% increase year-over-year.
- ALTIMMUNE, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-09-30 was $121.00K, a 7.63% decline year-over-year.
- ALTIMMUNE, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-03-31 was $170.00K, a 0.59% increase year-over-year.
- ALTIMMUNE, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2024-09-30 was $131.00K, a 63.75% increase year-over-year.
- ALTIMMUNE, INC. stock issued during period, value, employee stock purchase plan for fiscal 2025 was $291.00K, a 3.00% decline from fiscal 2024.
- ALTIMMUNE, INC. stock issued during period, value, employee stock purchase plan for fiscal 2024 was $300.00K, a 39.53% increase from fiscal 2023.
- ALTIMMUNE, INC. stock issued during period, value, employee stock purchase plan for fiscal 2023 was $215.00K, a 18.78% increase from fiscal 2022.
- ALTIMMUNE, INC. stock issued during period, value, employee stock purchase plan for fiscal 2022 was $181.00K, a 19.56% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-03-31 | $177.00K 10-Q · filed 2026-08-12 | |
| 2025-12-31 | $291.00K 10-K · filed 2026-03-06 | |
| 2025-09-30 | $121.00K 10-Q · filed 2025-11-06 | |
| 2025-03-31 | $170.00K 10-Q · filed 2026-08-12 | |
| 2024-12-31 | $300.00K 10-K · filed 2026-03-06 | |
| 2024-09-30 | $131.00K 10-Q · filed 2025-11-06 | |
| 2024-03-31 | $169.00K 10-Q · filed 2025-11-06 | |
| 2023-12-31 | $215.00K 10-K · filed 2025-02-27 | |
| 2023-09-30 | $80.00K 10-Q · filed 2024-11-12 | |
| 2023-03-31 | $135.00K 10-Q · filed 2024-11-12 | |
| 2022-12-31 | $181.00K 10-K · filed 2024-03-27 | |
| 2022-09-30 | $68.00K 10-Q · filed 2023-11-07 | |
| 2022-03-31 | $113.00K 10-Q · filed 2023-11-07 | |
| 2021-12-31 | $225.00K 10-K · filed 2023-02-28 | |
| 2021-09-30 | $119.00K 10-Q · filed 2022-11-10 | |
| 2021-03-31 | $106.00K 10-Q · filed 2022-11-10 | |
| 2020-12-31 | $135.47K 10-K · filed 2022-03-15 | |
| 2020-09-30 | $78.73K 10-Q · filed 2021-11-09 | |
| 2020-03-31 | $56.74K 10-Q · filed 2021-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |